Generic drugs result in Rs 2,000 cr benefits for common people

Image
Press Trust of India New Delhi
Last Updated : Jul 09 2019 | 2:00 PM IST

The government Tuesday said that generic drugs have resulted in benefits worth Rs 2,000 crore for common people.

Minister of State for Chemicals and Fertilisers Mansukh Mandaviya said all manufacturers of scheduled medicines, branded or generic, have to sell their products within the ceiling price fixed by the National Pharmaceutical Pricing Authority (NPPA). Local taxes would also be applicable on the medicines.

During the Question Hour in the Lok Sabha, he said generic drugs have helped in benefits worth Rs 2,000 crore for common people.

He also mentioned various steps taken by the government, including fixing ceiling prices for over 1,000 medicines and reducing medical costs for cardiac patients.

"The medicines sold under the Pradhan Mantri Bhartiya Janaushadi Pariyojana (PMBJP) are generic and normally cheaper by 50-90 per cent of average price of top three brands of corresponding medicines," the minister said.

The minister also urged members to encourage setting up of more Janaushadi outlets.

As many as 5,028 PMBJP kendras were opened during the last five years.

Currently, the product basket of PMBJP comprises 900 medicines and 154 surgicals and consumable items. Out of them, 714 medicines and 53 surgicals are presently available for sale at the kendras, the minister said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 09 2019 | 2:00 PM IST

Next Story